STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #362 by analyst upside · 2026-06-27
COCH
Envoy Medical, Inc.
Healthcare · Market Cap $51M · P/E 0x
ANALYST PRICE TARGET
+275.1%
implied upside to consensus target
Current Price $0.67
Consensus Target $2.5
Bull Target $2.5
Bear Target $2.5
Analysts Covering 1
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
1
Hold
0
Sell
0
52-Week Low $0.36
52-Week High $1.89
YTD Return -4.2%
FUNDAMENTALS
Market Cap $51M
P/E Ratio (TTM) N/A
Forward P/E -2.2x
EPS (TTM) $-1.02
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.36
52-Week High $1.89
Current Price $0.67
Bear Target $2.5
Bull Target $2.5
● Now $0.67 ● Target $2.5
TRADING DATA
Avg Volume 306K
YTD Return -4.2%
Analyst Count 1
Consensus Buy
Upside to Target +275.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Envoy Medical, Inc. (COCH) is currently trading at $0.67 with a Wall Street consensus price target of $2.5, implying potential upside of 275.1% over the next 12 months. 1 analysts currently cover COCH, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $2.5, while the most cautious has a target of $2.5.

COCH operates in the Healthcare sector with a market capitalisation of $51M. The stock is down 4.2% year-to-date and is currently trading near the lower end of its 52-week range of $0.36 – $1.89.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for COCH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

HC Wainwright & Co. ● Initiated
Buy 2026-03-31 31% win rate (48 calls)
Ascendiant Capital — Reiterated
Buy → Buy 2025-05-27 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-04-21 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2024-12-06 Building track record
Brookline Capital ● Initiated
Buy 2024-10-14 20% win rate (5 calls)
Ascendiant Capital — Reiterated
Buy → Buy 2024-09-03 Building track record
Ascendiant Capital ● Initiated
Buy 2024-06-24 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
40
out of 100
Coverage depth
5/30
Consensus clarity
8/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →